Document is current
Any future updates will be listed below
-
Authors
Fattore, Davide
Starace, Michela Valeria
Serra-García, Laura
Schmitt, Antonin
Scotté, Florian
-
Funding
Funding for this research was provided by:
Pierre Fabre
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 29 October 2025
First Online: 17 November 2025
Declarations
:
: Davide Fattore has received consulting fees from Pierre Fabre and L’Oreal; has received honoraria for lectures, presentations, speakers bureaus, manuscript writing and/or educational events from Sifarma; has participated on Data Safety Monitoring Board or Advisory Board for Pierre Fabre. Michela Valeria Starace has no conflict of interest to declare. Laura Serra-García has received honoraria for participation in advisory boards from Pierre Fabre. Antonin Schmitt has received honoraria for participation in advisory boards from Pierre Fabre. Florian Scotté has received honoraria for lectures, presentations, speakers bureaus, manuscript writing and/or educational events from Avene, BMS, Chugai, Daiichi Sankyo, Gilead, Grünenthal, GSK, Helsinn, Leo Pharma, MSD, Pfizer, Pharmanovia, Sandoz, Sanofi, Thermofisher, Viatris-Mylan.
